← Product Code [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX) · K032864

# CERALAS D 810 DIODE LASER SYSTEM, MODEL D15 (K032864)

_Biolitec, Inc. · GEX · Mar 19, 2004 · General, Plastic Surgery · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K032864

## Device Facts

- **Applicant:** Biolitec, Inc.
- **Product Code:** [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX.md)
- **Decision Date:** Mar 19, 2004
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 878.4810
- **Device Class:** Class 2
- **Review Panel:** General, Plastic Surgery
- **Attributes:** Therapeutic

## Intended Use

The Ceralas D 810 is intended for delivery of laser light to soft tissue in the contact or non-contact mode during surgical procedures, including via endoscopes, introducers, or catheters. The Ceralas D 810 is generally indicated for incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue in ear, nose and throat and oral surgery (otolaryngology), dental procedures, arthroscopy, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, urology, gynecology, neurosurgery (peripheral nervous system), pulmonary surgery, and cardiothoracic surgery. This Ceralas D 810 is specifically indicated for hemostasis or coagulation of soft tissue (including cardiac tissue).

## Device Story

Ceralas D 810 Diode Laser System delivers laser light to soft tissue; contact or non-contact modes; used via endoscopes, introducers, or catheters. Operated by surgeons in clinical settings for incision, excision, vaporization, ablation, hemostasis, or coagulation. Specifically indicated for cardiac tissue hemostasis/coagulation. Provides thermal energy to target tissue; enables precise surgical intervention; benefits patient through controlled tissue management.

## Clinical Evidence

Bench testing only. Device complies with 21 C.F.R. 11, IEC 601-1, IEC 601-2-22, and EN 60825-1 standards.

## Technological Characteristics

Diode laser system; contact/non-contact delivery; compatible with endoscopes, introducers, and catheters. Complies with IEC 601-1, IEC 601-2-22, and EN 60825-1 standards.

## Regulatory Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

## Predicate Devices

- Ceralas D 810 Diode Laser System
- Ceralas D 980 Diode Laser System
- CardioFocus, Inc.'s Diode Laser System used with CardioFocus, Inc.'s Surgical Lightstic

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

MAR 1 9 2004

#### 510(k) Summary Ceralas D 810 Diode Laser System × × 328 × 4

## Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared

biolitec. Inc. 515 Shaker Road East Longmeadow, Massachusetts 01028 (413) 525-0600 Phone: Facsimile: (413) 525-0611

Carol J. Morello, V.M.D. Contact Person: March 18, 2004 Date prepared:

## Name of Device and Name/Address of Sponsor

Ceralas D 810 Diode Laser System biolitec. Inc. 515 Shaker Road East Longmeadow, Massachusetts 01028

#### Classification Name

Surgical laser

## Predicate Devices

Ceralas D 810 Diode Laser System Ceralas D 980 Diode Laser System CardioFocus, Inc.'s Diode Laser System used with CardioFocus, Inc.'s Surgical Lightstic

#### Intended Use/Indication for Use

The Ceralas D 810 is intended for delivery of laser light to soft tissue in the contact or non-contact mode during surgical procedures, including via endoscopes, introducers, or catheters. The Ceralas D 810 is generally indicated for incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue in ear, nose and throat and oral surgery (otolaryngology), dental procedures, arthroscopy, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, urology, gynecology, neurosurgery (peripheral nervous system), pulmonary surgery, and

{1}------------------------------------------------

cardiothoracic surgery. This Ceralas D 810 is specifically indicated for hemostasis cartion of soft tissue (including cardiac tissue).

## Performance Data

The device complies with the following voluntary consensus standards: 21 C.F.R. 11te device complics with and Addinest; IEC 601-1; IEC 601-2-22; and EN 60825-1.

## Substantial Equivalence

The Ceralas D 810 has the same intended use and the exact same technological The Ocrains I 810 with the exceptiously cleared Ceralas D 810 with the exception of a characterismes to the phe handpiece for hemostasis or coagulation of cardiac tissue. In addition, all of the Ceralas D 810's general and specific indications for use are In additions of at least one of its predicate devices. The Ceralas D 810 also has very similar technological characteristics as its predicate devices. Thus, the Ceralas D 810 is substantially equivalent.

{2}------------------------------------------------

FEB 2 1 2008

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Biolitec. Inc. c/o Mr. Jonathan S. Kahan Hogan & Hartson, L.L.P. 555 Thirteenth Street, NW Washington, DC 20004

Re: K032864

Trade/Device Name: Cardiac Ceralas D 810 Diode Laser System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II (two) Product Code: OCL, GEX Dated: December 22, 2003 Received: December 22, 2003

Dear Mr. Kahan:

This letter corrects our substantially equivalent letter of March 19, 2004.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Mr. Jonathan Kahan

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

el.mall.

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use Statement

510(k) Number (if known):_K 032864

Device Name: Ceralas D 810 Diode Laser System

The Ceralas D 810 is intended for delivery of laser light to soft tissue in the contact or non-contact mode during surgical procedures, including via endoscopes, introducers, or catheters. The Ceralas D 810 is generally indicated for incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue in ear, nose and throat and oral surgery (otolaryngology), dental procedures, arthroscopy, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, urology, gynecology, neurosurgery (peripheral nervous system), pulmonary surgery, and cardiothoracic surgery. This Ceralas D 810 is specifically indicated for hemostasis or coagulation of soft tissue (including cardiac tissue).

# (PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| Prescription Use | X (Per 21 C.F.R. 801.109) |
|------------------|---------------------------|
|------------------|---------------------------|

OR

| Over-The-Counter Use | _ (Optional Format 1-2-96) |
|----------------------|----------------------------|
|----------------------|----------------------------|

  

Miriam C. Provost
  

(Division Sign-Off)
  

Division of General, Restorative,
and Neurological Devices

| 510(k) Number | K632864 |
|---------------|---------|
|---------------|---------|

510(k) Number.

---

**Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K032864](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K032864)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com